| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 4,814 | 4,206 | 3,488 | 3,626 | | Cost of Revenue | 4,242 | 2,520 | 2,094 | 2,964 | | | Gross Profit | 572 | 1,686 | 1,394 | 662 | | | Operating Expenses | | Research Development | 1,230 | 1,625 | 2,012 | 2,268 | | Selling General and Administrative | 5,340 | 5,409 | 6,101 | 5,557 | | Non Recurring | 15 | 129 | 712 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (6,013) | (5,477) | (7,431) | (7,163) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 376 | (735) | 34 | 1,185 | | Earnings Before Interest And Taxes | (5,637) | (6,212) | (7,397) | (5,978) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (5,637) | (6,212) | (7,397) | (5,978) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,637) | (6,212) | (7,397) | (5,978) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,637) | (6,212) | (7,397) | (5,978) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,637) | ($6,212) | ($7,397) | ($5,978) |
|
0.51% Nasdaq 0.00%
Income Statement
